Larmorbio

Larmor Bio(est 2022) is a Massachusetts Institute of Technology spin-off is a Biotechnology company advancing development and commercialization of proprietary bioplatform technologies capable of high resolution molecular phenotyping of various microsized biological samples. The platform consists of proprietary compact instruments, proprietary software, and proprietary consumables. Unlike existing methods, our methodology doesn’t require the use of harsh chemical reagents and extensive sample preparation. We analyze “live” biology obtaining an unprecedented level of detail that enables rapid, onsite, answers to complex biological problems cost-effectively. We expect our proprietary Bioplatform to revolutionize medical diagnostics and digital health monitoring technology, in large, addressable, growing markets with significant unmet needs.